Chromatin (Chicago, IL) a commercial-stage bioenergy market company focused on crop improvement and biomass feedstocks for the renewable energy sector closed a $10.4M Series D financing. Participants include BP Ventures, Unilever Technology Ventures, Quantitative Investment Holdings, Malaysian Life Sciences Capital Fund and Illinois Ventures.